Design, synthesis, and PASS-assisted evaluation of novel 2-substituted benzimidazole derivatives as potent anthelmintics
Tóm tắt
A series of novel 2-substituted benzimidazole analogs has been designed and synthesized by connecting the benzimidazole nucleus with variedly substituted chalcone moieties through an amino linker. The designed analogs were predicted for their biological activity profile through the computer software PASS. The compounds were predicted to have potent anthelmintic activity. These were synthesized and the activity of each compound was evaluated experimentally at the concentrations of 0.1, 0.2, and 0.5 % in terms of mortality time and paralysis time for the helminthes. The experimentally observed activity was found to comply with the PASS predicted activity. All compounds showed dose-dependent activities. The compounds with an electron releasing group at the para position on phenyl ring in the chalcone moiety (8 and 9) were the most active in comparison to those bearing electron withdrawing groups. The corresponding ortho analogs (4 and 5) also revealed good paralytic and lethal activities. The higher activities of 8 and 9 may be attributed to the favorable electronic interactions of the electron releasing groups present at para position of the phenyl ring. Comparative analysis of the Lipinski’s parameters and the activities of the compounds revealed all the compounds to comply with the Lipinski’s rule of five. Further an optimum hydrophilicity and total polar surface area in the range of 65–80 of the molecule are required for the potent activity, but Molar refractance is not found to have any significant role in determining the anthelmintic activity.
Tài liệu tham khảo
Ajaiyeoba EO, Onocha PA, Olarenwaju OT (2001) In vitro anthelmintic properties of Buchholzia coriaceae and Gynandropsis gynandra extract. Pharm Biol. 39:217–220
Akul G, Srinivas B, Vidyasagar M, Kandikonda S (2011) Synthesis of 3-(1H-benzimidazol-2-yl-amino)-2-phenyl-1,3-thiazolidin-4-one as potential CNS depressant. Int J Pharm Tech Res. 3:360–364
Babu IS, Selvakumar S (2012) Synthesis, characterization, antibacterial and antifungal activities of some potent 2-substituted benzimidazolyl chalcones. Int J Biol Pharm Res. 3:275–283
Bansal Y, Silakari O (2012) Therapeutic journey of benzimidazole: a review. Bioorg Med Chem 20(21):6208–6236
Caroti P, Ceccotti C, Settimo FD, Primofiore G, Franzone JG, Reboani MC, Cravanzola C (1989) Synthesis, antilipidemic and platelet antiaggregatory activity of 2-aminobenzimidazole amide derivatives. Farmaco 44:227–255
Dash GK, Suresh P, Kar DM, Ganpaty S, Panda SB (2002) Evaluation of Evolvulus alsinoides Linn. for anthelmintic and antimicrobial activities. J Nat Rem. 2:182–185
Di Carlo G, Mascolo N, Izzo AA, Capasso F (1999) Flavanoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 65(4):337–353
Dimmock JR, Elias DW, Beazely MA, Kandepu NM (2005) Bioactivities of chalcones. Curr Med Chem 12:481–499
Kosalge SB, Fursule RA (2009) Investigation of in vitro anthelmintic activity of Thespesia lampas (Cav.). Asian J Pharm Clin Res. 2:69–71
Leonard NL, Daviy CY, Karl BM (1947) Sulfonate salts of substituted benzimidazoles. J Med Chem 69:2459–2461
Lipinski CA, Lombardo F, Dominy BW, Feeney P (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. J Adv Drug Deliv Rev. 46:3–26. Calculation of molecular properties and bioactivity score was done by software available at website http://www.molinspiration.com/
Marawaha A, Goel RK, Mahajan MP (2007) PASS-predicted design, synthesis and biological evaluation of cyclic nitrones as nootropics. Bioorg Med Chem Lett 17:5251–5255
Mathew B, Suresh J, Anbazhagan S (2012) Development of novel (1H) benzimidazole bearing pyrimidine-trione based MAO-A inhibitors: synthesis, docking studies and antidepressant activity. J Saudi Chem Soc. doi:10.1016/j.jscs.2012.09.015
Mishra L, Sinha R, Itokawa H, Kenneth FB, Tachibana Y, Nakanishi Y, Kilgore N, Lee KH (2001) Anti-HIV and cytotoxic activities of Ru(II)/Ru(III) polypyridyl complexes containing 2,6-(2′-Benzimidazolyl)-pyridine/chalcone as co-ligand. Biorg Med Chem. 9:1607–1617
Mor M, Bordi F, Silva C, Rivara S, Zuliani V, Vacondio F, Rivara M, Barocelli E, Bertoni S, Ballabeni V, Magnanini F, Impicciatore M, Plazzi PV (2004) Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Bioorg Med Chem 12:663–674
Navrocka W (1996) Synthesis and pharmacological properties of new 2-aminobenzimidazole derivatives. Boll Chim Farm 135:18–23
Nawrocka W, Sztuba B, Kowalska MW, Liszkiewicz H, Wietrzyk J, Nasulewicz A, Pełczyńska M, Opolski A (2004) Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives. Farmaco 59:83–91
Poroikov VV, Filimonov DA, Borodina VY, Lagunin AA, Kos A (2000) Robustness of biological activity spectra predicting by computer program PASS for non congeneric sets of chemical compounds. J Chem Inf Comput Sci 40:1349–1355
Settimo AD, Marini AM, Primofiore G, Subissi A (1991) Synthesis and antihypertensive activity of some 2-aminobenzimidazole and indole derivatives. Farmaco 46:357–367
Shaharyar M, Abdullah MM, Bakht MA, Majeed J (2010) Pyrazoline bearing benzimidazoles: search for anticancer agents. Eur J Med Chem 45:114–119
Shivkumar YM, Kumar VL (2003) Anthelmintic activity of latex of Calotropis procera. Pharma Biol. 41:263–265
Wang R, Lu X, Yu X, Shi L, Sun Y (2007) Acid-catalyzed solvent-free synthesis of 2-arylbenzimidazoles under microwave irradiation. J Mol Catal A. 266:198–201
Zdzislawa N (2007) A review of anti-infective anti-inflammatory chalcones. Eur J Med Chem 42:125–137